Abcellera Biologics
Price & Volume
Stats
See more52W Range | $1.89-$6.51 |
Market Cap | $1.1B |
Shares Short | 53M |
Financials
See moreRevenue (12 Mos) | $35.3M |
Revenue Growth (YoY) | 37.6% |
Gross Profit (12 Mos) | -$131.9M |
Diluted EPS | -$0.57 |
News
See moreYahoo Finance • 7 hours ago
After-Hours Biotech Watch: IFRX, ABCL, RLYB Among Notable Risers
Yahoo Finance • 4 days ago
Here are the major earnings after the close Thursday
Yahoo Finance • last month
Nuvation Bio Inc. (NUVB): A Bull Case Theory
Yahoo Finance • 2 months ago
TD Cowen Reiterates Buy Rating on ABCL After AbCellera Biologics Dosed First Participants of ABCL575
About
CEO | Dr. Carl L.G. Hansen Ph.D. |
Address | 150 West 4th Ave, Vancouver, BC, Canada, V5Y 1G6 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 596 |
